News - Page 232 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Post published:December 14, 2020
Post category:Press Release

Read more about the article Red Light Holland and Disruptive Pharma Announce Intention to Form Joint Venture in Brazil

Red Light Holland and Disruptive Pharma Announce Intention to Form Joint Venture in Brazil

Post published:December 14, 2020
Post category:Press Release

Read more about the article CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

CYBIN Closes Acquisition of Adelia Therapeutics; Bolsters Scientific Team and Grows IP Portfolio to 7 Patent Filings

Post published:December 14, 2020
Post category:Press Release

Read more about the article MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for Project Lucy

Post published:December 14, 2020
Post category:Press Release

Read more about the article Lars Wilde, Co-founder of COMPASS Pathways

Lars Wilde, Co-founder of COMPASS Pathways

Post published:December 13, 2020
Post category:Interview

Read more about the article Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment

Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment

Post published:December 12, 2020
Post category:Analysis News

Read more about the article Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

Post published:December 11, 2020
Post category:Press Release

Read more about the article MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)

MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m)

Post published:December 11, 2020
Post category:Press Release

Read more about the article Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial

Psychedelic Bulletin: Canadian Healthcare Professionals Allowed Psilocybin; UK Approves DMT Trial

Post published:December 11, 2020
Post category:Psychedelic Bulletin

Read more about the article Andrew Chadeayne, Founder and CEO of CaaMTech

Andrew Chadeayne, Founder and CEO of CaaMTech

Post published:December 10, 2020
Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.